MarketPeel
Insider Trading Intelligence
Pricing
…
AM

Aziz Mottiwala

TARS
CHIEF COMMERCIAL OFFICER · TARSUS PHARMACEUTICALS, INC. · CIK 0001788542
FILING MIX · LIFETIME33%/67%
BUYS
19
SELLS
39
TOTAL VALUE
$3.07M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
61,480
AVG SELL PX
$35.05
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
25 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Aziz Mottiwala, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d25+56.00%-0.83%+0.60%-1.43%-1.18%—
14d25+60.00%-1.59%+0.93%-2.52%-2.37%—
30d25+68.00%-1.18%+0.98%-2.16%-7.22%—
60d25+64.00%+1.65%+5.08%-3.43%-14.38%—
90d25+68.00%-0.56%+5.91%-6.47%-19.19%—
180d25(3 pending)+45.45%-1.64%+6.24%-7.88%-11.12%—
1y25(3 pending)+27.27%+54.00%+13.80%+40.21%+23.79%—
2y25(7 pending)+33.33%+126.28%+29.01%+97.27%+88.92%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 61,480 shares · as of Mar 19, 2026
018,90637,81156,71775,62220222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 19 buys / 39 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,440$67.00$297.5K61,480Mar 19, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,330$68.71$297.5K65,920Mar 18, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,286$69.42$297.5K70,250Mar 17, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
8,148——8,148Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
26,482——74,536Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,790——0Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
5,524——16,574Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
8,020——16,040Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,306——19,306Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,724——30,724Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
17,500$43.76$765.8K47,557Jun 9, 2025Jun 11, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
3,365$50.11$168.6K65,057Mar 20, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
3,557$47.40$168.6K68,422Mar 19, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
3,643$46.29$168.6K71,979Mar 18, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
8,148——16,296Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
8,019——24,060Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
20,957——75,622Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,790——4,790Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,098——22,098Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,691——33,691Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,766$30.60$145.8K54,075Mar 18, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
8,148——24,444Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,790——9,580Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
12,938——58,841Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,079——32,079Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
47,500——47,500Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,400$20.05$48.1K45,806Jul 19, 2023Jul 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$20.00$2.0K48,086Jun 8, 2023Jun 12, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,500$19.34$48.4K48,186Jun 7, 2023Jun 8, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,143$18.61$39.9K50,686Jun 6, 2023Jun 8, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
372$12.15$4.5K52,829Mar 23, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
357$12.64$4.5K53,201Mar 22, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
349$12.89$4.5K53,558Mar 21, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
358$12.61$4.5K53,907Mar 20, 2023Mar 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
339$13.28$4.5K54,265Mar 17, 2023Mar 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
336$13.43$4.5K54,604Mar 16, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,790——14,370Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
4,790——54,940Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,592——32,592Mar 8, 2023Mar 10, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
48,116——48,116Mar 8, 2023Mar 10, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
6,857$17.72$121.5K49,729Nov 15, 2022Nov 17, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,416$10.99$48.5K10,573Aug 24, 2022Aug 26, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
4,416$10.99$48.5K55,814Aug 24, 2022Aug 26, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
772$0.45$34756,586Aug 24, 2022Aug 26, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
772$0.45$3470Aug 24, 2022Aug 26, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
65,312——65,312Mar 9, 2022Mar 11, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,160——19,160Mar 9, 2022Mar 11, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
1,889$28.11$53.1K50,203Nov 8, 2021Nov 10, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
11$28.11$30952,092Nov 5, 2021Nov 8, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
100$28.03$2.8K52,103Nov 4, 2021Nov 8, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
5,458$26.75$146.0K52,745Nov 2, 2021Nov 4, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
542$27.07$14.7K52,203Nov 2, 2021Nov 4, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
2,593$0.45$1.2K60,796Sep 10, 2021Sep 14, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
2,593$22.15$57.4K58,203Sep 10, 2021Sep 14, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
4,350$10.99$47.8K58,203Sep 10, 2021Sep 14, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
2,593$0.45$1.2K772Sep 10, 2021Sep 14, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
4,350$10.99$47.8K14,989Sep 10, 2021Sep 14, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,999——40,999Jan 7, 2021Jan 8, 2021 ↗View →
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001788542
ROLE
Chief Commercial Officer
PRIMARY
TARS
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001788542DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback